# Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)

> **NCT01366898** · PHASE4 · UNKNOWN · sponsor: **PETHEMA Foundation** · enrollment: 100 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Dexamethasona, Idarubicine, ARA-C, Methotrexate

## Key facts

- **NCT ID:** NCT01366898
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06-30
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366898, "Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01366898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*